Homocysteine (Hcy) assessment to predict outcomes of hospitalized Covid-19 patients: a multicenter study on 313 Covid-19 patients

Clin Chem Lab Med. 2021 Mar 26;59(9):e354-e357. doi: 10.1515/cclm-2021-0168. Print 2021 Aug 26.

¹ Division of Clinical Pathology, Department of Surgical, Medical, Dental and Morphological Sciences with Interest in Transplant, Oncological and Regenerative Medicine, University of Modena and Reggio Emilia, Modena, Italy.
² Department of Laboratory Medicine, OCSAE, Azienda USL of Modena, Modena, Italy.
³ Internal Medicine, Ospedale del Mare, Asl Napoli1, Naples, Italy.
⁴ Dermatology Unit, University of Modena and Reggio Emilia, Modena, Italy.
⁵ Clinical and Experimental Medicine (CEM), Department of Surgical, Medical, Dental and Morphological Sciences with Interest in Transplant, Oncological and Regenerative Medicine, University of Modena and Reggio Emilia, Modena, Italy.
⁶ Covid Hospital Boscotrecase Operative Unit of Medicine, Napoli, Italy.
⁷ Cardarelli Hospital, Napoli, Italy.
⁸ Department of Clinical Biochemistry, Medical Faculty, Akdeniz University, Antalya, Turkey.
⁹ Internal Medicine, Cardarelli Hospital, Napoli, Italy.
¹⁰ Dia-Chem srl, Napoli, Italy.

No abstract available

Keywords: Covid-19 vulnerability; MTHFR gene; MTHFR677C>T mutations; biomarkers; homocysteine (Hcy); predictor parameters.

Publication types